Table 4 Univariable and multivariable Cox regression models for cancer-specific and overall survival according to G-cross (Gtumour:T cell) proximity function values at 20 µm radius and T cell densities.

From: Prognostic significance of spatial and density analysis of T lymphocytes in colorectal cancer

  

Colorectal cancer-specific survival

Overall survival

 

No. of cases

No. of events

Univariable HR (95% CI)

Multivariable HR (95% CI)

No. of events

Univariable HR (95% CI)

Multivariable HR (95% CI)

CD3+ cell proximity

Tumour center

  Q1

246

100

1 (referent)

1 (referent)

152

1 (referent)

1 (referent)

  Q2

246

82

0.75 (0.56–1.00)

0.88 (0.65–1.18)

135

0.81 (0.64–1.02)

0.86 (0.68–1.08)

  Q3

246

55

0.48 (0.34–0.67)

0.65 (0.46–0.91)

114

0.64 (0.50–0.81)

0.75 (0.58–0.96)

  Q4

245

33

0.26 (0.18–0.39)

0.45 (0.30–0.68)

93

0.47 (0.36–0.61)

0.57 (0.43–0.75)

  Ptrend

  

<0.0001

<0.0001

 

<0.0001

<0.0001

Invasive margin

  Q1

246

106

1 (referent)

1 (referent)

158

1 (referent)

1 (referent)

  Q2

246

91

0.84 (0.63–1.11)

0.93 (0.70–1.24)

137

0.84 (0.67–1.06)

0.88 (0.70–1.11)

  Q3

246

45

0.35 (0.25–0.50)

0.61 (0.42–0.88)

94

0.48 (0.37–0.62)

0.66 (0.50–0.86)

  Q4

245

28

0.22 (0.15–0.34)

0.35 (0.22–0.55)

105

0.53 (0.42–0.68)

0.62 (0.47–0.81)

  Ptrend

  

<0.0001

<0.0001

 

<0.0001

<0.0001

CD8+ cell proximity

Tumour center

  Q1

246

95

1 (referent)

1 (referent)

146

1 (referent)

1 (referent)

  Q2

246

82

0.85 (0.63–1.15)

1.08 (0.80–1.46)

135

0.91 (0.72–1.14)

1.04 (0.82-1.32)

  Q3

246

57

0.54 (0.39–0.75)

0.77 (0.55–1.08)

110

0.65 (0.51–0.84

0.81 (0.63–1.04)

  Q4

245

36

0.33 (0.22–0.48)

0.59 (0.39–0.89)

103

0.58 (0.45–0.74)

0.75 (0.57–0.98)

  Ptrend

  

<0.0001

0.006

 

<0.0001

0.012

Invasive margin

  Q1

246

110

1 (referent)

1 (referent)

151

1 (referent)

1 (referent)

  Q2

246

80

0.70 (0.53–0.94)

0.70 (0.52–0.94)

135

0.85 (0.67–1.07)

0.90 (0.71–1.14)

  Q3

246

49

0.38 (0.27–0.53)

0.57 (0.40–0.82)

99

0.54 (0.42–0.70)

0.71 (0.55–0.93)

  Q4

245

31

0.24 (0.16–0.35)

0.38 (0.25–0.58)

109

0.59 (0.46–0.75)

0.70 (0.53–0.91)

  Ptrend

  

<0.0001

<0.0001

 

<0.0001

0.003

CD3+ cell density

Tumour center

  Q1

246

92

1 (referent)

1 (referent)

151

1 (referent)

1 (referent)

  Q2

246

85

0.88 (0.66–1.19)

1.17 (0.86–1.59)

135

0.85 (0.67–1.07)

1.14 (0.89–1.45)

  Q3

246

54

0.50 (0.36–0.70)

0.71 (0.50–1.00)

105

0.58 (0.45–0.75)

0.79 (0.61–1.02)

  Q4

245

39

0.31 (0.25–0.52)

0.52 (0.35–0.76)

103

0.56 (0.43–0.71)

0.67 (0.52–0.87)

  Ptrend

  

<0.0001

0.0001

 

<0.0001

0.0003

Invasive margin

  Q1

246

98

1 (referent)

1 (referent)

152

1 (referent)

1 (referent)

  Q2

246

81

0.78 (0.58–1.05)

0.92 (0.68–1.24)

127

0.78 (0.61–0.98)

0.89 (0.70–1.13)

  Q3

246

55

0.50 (0.36–0.69)

0.66 (0.47–0.93)

114

0.65 (0.51–0.83)

0.75 (0.58–0.96)

  Q4

245

36

0.31 (0.21–0.45)

0.48 (0.32–0.71)

101

0.54 (0.42–0.69)

0.61 (0.47–0.80)

  Ptrend

  

<0.0001

<0.0001

 

<0.0001

0.0002

CD8+ cell density

Tumour center

  Q1

246

90

1 (referent)

1 (referent)

145

1 (referent)

1 (referent)

  Q2

246

78

0.84 (0.62–1.13)

0.97 (0.71–1.31)

128

0.85 (0.67–1.08)

0.95 (0.74–1.20)

  Q3

246

57

0.59 (0.42–0.82)

0.74 (0.52–1.04)

117

0.73 (0.57–0.93)

0.83 (0.65–1.06)

  Q4

245

45

0.44 (0.31–0.63)

0.65 (0.45–0.95)

104

0.61 (0.48–0.79)

0.73 (0.56–0.95)

  Ptrend

  

<0.0001

0.010

 

<0.0001

0.011

Invasive margin

  Q1

246

105

1 (referent)

1 (referent)

155

1 (referent)

1 (referent)

  Q2

246

62

0.51 (0.37–0.69)

0.73 (0.53–1.02)

112

0.60 (0.47–0.76)

0.76 (0.59–0.97)

  Q3

246

61

0.51 (0.37–0.70)

0.65 (0.47–0.90)

114

0.64 (0.50–0.81)

0.72 (0.56–0.93)

  Q4

245

42

0.34 (0.24–0.49)

0.53 (0.37–0.78)

113

0.61 (0.48–0.78)

0.72 (0.56–0.94)

  Ptrend

  

<0.0001

0.0004

 

0.0003

0.013

  1. Analyses were done separately for CD3+ and CD8+ cells in tumour center and in invasive margin by using ordinal quartile categories (Q1–Q4, from low to high).
  2. Multivariable Cox proportional hazards regression models were adjusted for sex, age (<65, 65–75, >75), year of operation (2000–2005, 2006–2010, 2011–2015), tumour location (proximal colon, distal colon, rectum), disease stage (I–II, III, IV), tumour grade (well/moderately differentiated, poorly differentiated), lymphovascular invasion (negative, positive), MMR status (proficient, deficient), BRAF status (wild-type, mutant).
  3. Ptrend values were calculated by using the four ordinal categories of G-cross (Gtumour:T cell) proximity function values at 20 µm radius and T cell densities as continuous variables in univariable and multivariable Cox proportional hazard regression models.
  4. CI confidence interval, HR hazard ratio.